ADC Antibody Development

Based on “Integrated and Innovative Antibody-drug Conjugates R&D Platform” and “Super Trillion Antibody Library Platform”, we can customize the screening of the best antibody suitable for ADC drug development for partners, and can also provide overall R&D services for ADC drugs from target to Pre-clinical candidates.

Service Highlights

1. Integrated platform for innovative ADC discovery

• 10 functional modules and 40+ sub-platforms cover the whole antibody discovery process.

• Professional project management system, seamless integration among all modules, and high efficiency for PCC completion (12 months).

2. Unique multi-pathway antibody generation platform

• Seven trillion large-capacity antibody library, thousands of lead molecules for conventional targets can be obtained.

• Diverse antibody sources: natural B-cell antibodies, B-cell rearranged antibodies, synthetic and semi-synthetic antibodies, mouse immunization library, alpaca immunization library.

• Full coverage of molecular formats: full antibodies, single domain antibodies, bispecific antibodies, mouse monoclonal antibodies, rat monoclonal antibodies.

3. Rapid & high-throughput conjugation platform

• High-throughput, stable and controlled conjugation platform for efficient screening of lead antibodies.

• Multiple conjugation methods evaluation: flexible combination of payloads and linkers.

4. Experienced & professional research team

• 20+ scientists in various fields, systematic and scientific project development.

• 100+ projects development experience, high rate for successful project deliver.

5. Flexible customization services

• Customized innovative ADC R&D with diversified service forms.

• Flexible combination of ADC three core elements to suit different R&D needs.